Characteristics | No. of tumors examined | WT | EGFR mutation | (%) | p |
Total | 103 | 76 | 27 | (26) |
|
Age (mean) | 67.0 | 3.2 | 63.8 |
|
|
Gender |
|
|
|
|
|
Male | 74 | 64 | 10 | (14) |
|
Female | 29 | 12 | 17 | (59) | <0.00001 |
Smoking status |
|
|
|
|
|
Never | 26 | 10 | 16 | (65) |
|
Ex-smoker | 26 | 20 | 6 | (23) |
|
Current | 51 | 46 | 5 | (12) | <0.00001 |
Smoking index |
|
|
|
|
|
<799 | 46 | 23 | 23 | (54) |
|
>800 | 57 | 53 | 4 | (7) | <0.000001 |
Histological differentiation |
|
|
|
|
|
Adenocarcinoma | 69 | 42 | 27 | (41) | <0.0001 |
Squamous cell ca. | 26 | 26 | 0 | (0) |
|
Adenosquamous ca. | 2 | 2 | 0 | (0) |
|
| 6 | 6 | 0 | (0) |
|
Adenocarcinoma | 69 | 42 | 27 | (41) |
|
Histological differentiation |
|
|
|
|
|
Well differentiated | 22 | 10 | 12 | (55) |
|
Moderately diff. | 37 | 22 | 15 | (41) | p < 0.05 |
Poorly differentiated | 10 | 10 | 0 | (0) |
|
Patholoical stage |
|
|
|
|
|
I | 36 | 21 | 15 | (42) | NS |
II | 13 | 8 | 5 | (38) |
|
III | 17 | 10 | 7 | (41) |
|
IV | 3 | 3 | 0 | (0) |
|
KRAS gene |
|
|
|
|
|
Mutated | 11 | 11 | 0 | (0) |
|
Not mutated | 92 | 65 | 27 | (32) | p < 0.05 |
CADM1 gene |
|
|
|
|
|
Methylated | 45 | 37 | 8 | (18) |
|
Unmethylated | 58 | 39 | 19 | (33) | NS |
4.1B gene |
|
|
|
|
|
Methylated | 59 | 47 | 12 | (20) |
|
Unmethylated | 44 | 29 | 15 | (34) | NS |
CADM1 or 4.1B gene |
|
|
|
|
|
Both or either methylated | 71 | 55 | 16 | (23) |
|
Both unmethylated | 32 | 21 | 11 | (34) | NS |